Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 15, 2018
Mustang Bio Announces Key Leadership Appointments
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a Fortress Biotech (FBIO) Company focused on the development of novel immunotherapies ...
March 15, 2018
Checkpoint Therapeutics Announces Preclinical Data Presentation at the 2018 American Association for Cancer Research Annual Meeting
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
March 15, 2018
Albireo Reports Fourth Quarter and Year-End 2017 Financial Results
BOSTON, March 15, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
March 15, 2018
La Jolla Pharmaceutical Company Announces Pricing of Public Offering of Common Stock
SAN DIEGO, March 15, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (LJPC) (La Jolla), a leader in the development of innovative therapies intended to ...
March 15, 2018
New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Annual Meeting 2018
AUSTIN, Texas, March 15, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered ...
March 15, 2018
Minerva Neurosciences to Host Key Opinion Leader Meeting on the Negative Symptoms of Schizophrenia on Thursday, March 22
WALTHAM, Mass., March 15, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a biopharmaceutical company focused on the development of therapies to treat central nervous ...
March 14, 2018
EDAP TMS SA : EDAP TMS to Announce Year End 2017 Financial Results on Tuesday, March 27, 2018
LYON, France, March 14, 2018 - EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results ...
March 14, 2018
Onxeo Provides Financial Update
PARIS--(BUSINESS WIRE)--Regulatory News:Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO FR0010095596), a biotechnology company specializing in the development of innovative drugs in oncology, and notably rare ...
March 14, 2018
La Jolla Pharmaceutical Company Announces $100 Million Public Offering of Common Stock
SAN DIEGO, March 14, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (LJPC) (La Jolla), a leader in the development of innovative therapies intended to ...
March 14, 2018
Late-Breaking Abstract Reporting SRA737 Preclinical Activity in CCNE1-Driven and PARPi-Resistant Cancers Accepted for AACR 2018 Annual Meeting
VANCOUVER , March 14, 2018 /CNW/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response ...
March 14, 2018
MediWound to Host Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call on March 19 at 8:30 a.m. Eastern Time
YAVNE, Israel, March 13, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
March 14, 2018
Auris Medical Provides Business Update
Zug, Switzerland, March 13, 2018 - Auris Medical Holding AG (EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in ...
March 14, 2018
Rockwell Medical, Inc. Appoints Two Independent and Experienced Life Sciences Executives to Board of Directors
WIXOM, Mich., March 13, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), (the “Company”) announced today that it has unanimously appointed Lisa Colleran and Benjamin ...
March 14, 2018
Kiadis Pharma to Present at the Cowen and Company 38th Annual Health Care Conference
Amsterdam, The Netherlands, March 14, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing ...
March 14, 2018
BioDelivery Sciences to Present at the Oppenheimer 28th Annual Healthcare Conference
RALEIGH, N.C., March 14, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company with a focus in pain management and addiction ...
March 14, 2018
MannKind Corporation to Present at Oppenheimer 28th Annual Healthcare Conference
WESTLAKE VILLAGE, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) focused on the development and commercialization of inhaled therapeutic products for patients with ...
March 14, 2018
FDA Acceptance of IND for Tyme to Begin Phase II Trial in Pancreatic Cancer
NEW YORK, March 14, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME) (“Tyme” or the “Company”) announced today that the U.S. Food and Drug Administration (“FDA”) ...
March 14, 2018
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
SAN DIEGO, March 14, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), today provided a corporate update and reported financial results for the fourth quarter and full-year ...
March 14, 2018
Lipocine to Present at the Oppenheimer 28th Annual Healthcare Conference
SALT LAKE CITY, March 14, 2018 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, announced today that Dr. Mahesh Patel, Chairman, President and CEO, will ...
March 14, 2018
Spring Bank Announces Presentation of Combined Inarigivir 25 mg and 50 mg 12 and 24 Week ACHIEVE Results Demonstrating Enhanced Anti-Viral Efficacy in HBeAg-Negative Patients
HOPKINTON, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH) today announced that Nezam Afdhal, M.D., D.Sc., chief medical officer of Spring ...
Page 110 of 169